Dehydroleucodine exerts an antiproliferative effect on human Burkitt’s lymphoma Daudi cells via SLC7A11-mediated ferroptosis
DhL shows strong potential as a novel chemotherapeutic agent for BL treatment by targeting SLC7A11-mediated ferroptosis. Further investigation is warranted to confirm its efficacy and clinical utility in diverse BL patient populations.
Authors
- Yemiao Chen (ORCID: https://orcid.org/0000-0001-5397-1407)
- Cheng Fang (ORCID: https://orcid.org/0000-0002-8626-9451)
- Yaokai Chen (ORCID: https://orcid.org/0000-0002-3229-0108)
- Xiaolong Yang (ORCID: https://orcid.org/0000-0002-8073-8675)
- Wenjing Wang (ORCID: https://orcid.org/0000-0001-9719-753X)
- Rui Guo (ORCID: https://orcid.org/0000-0002-2433-9995)
- Rui Shen (ORCID: https://orcid.org/0000-0001-8491-0471)
Institutions
- Minzu University of China (CN)
- Chongqing Public Health Medical Center (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-04-14
- DOI
- https://doi.org/10.3389/fphar.2025.1572364
- Citations
- 1
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 1.52